Warning: session_start(): open(/opt/alt/php74/var/lib/php/session/sess_fa34d692c65afd673d3ceeeeb7d5f1d5, O_RDWR) failed: Disk quota exceeded (122) in /home/useaicwl/public_html/wp-content/themes/mushroomstocks/functions.php on line 278

Warning: session_start(): Failed to read session data: files (path: /opt/alt/php74/var/lib/php/session) in /home/useaicwl/public_html/wp-content/themes/mushroomstocks/functions.php on line 278
Does Trump Have His Sights Set On Cannabis - Mushroomstocks | Mushroomstocks
Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human TrialsMindMed Reports Full Year 2022 Financial Results and Business HighlightsCybin to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceNuminus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023Irwin Naturals Signs Letter of Intent to Acquire Braxia ScientificNuminus Wellness Inc. Reports Q1 2023 ResultsIrwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical CompanNuminus Develops Mushroom Tea for Use in Psychedelic ResearchIs the Psychedelic Sector Poised for a Comeback?!?PSYC + Nucleus Form New Partnership to Develop and Launch Psychedelic FinderWhat You Need to Know About Numinus Wellness…Numinus provides update on acquisition integration and announces new client financing optionsPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Fourth Consecutive MonthNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022The Psychedelic Sector is Quietly Outperforming the S&P 500PSYC Completes and Publishes 2021 Audited Financials; Will Begin Audit of Q1 & Q2 2022Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PSYC’s Bonfire Platform Development Progresses; Will Host Free Virtual Community Event on August 29th

Does Trump Have His Sights Set On Cannabis

Mar 1, 2017 • 12:21 PM EST
Untitled design (20).png
5 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

Vice recently produced a highlight reel covering 24 things that President Trump claims to be the best at.

We went through this highlight reel and recapped five claims due to the immediate impact cannabis would have on them. The claims we chose from President Trump were:

1) There is no one is better to people with disabilities

2) There is no one fighting more for the veterans

3) He knows the most about trade

4) No one in the history of this country has ever known so much about infrastructure

5) No one knows more about debt than him

Cannabis Supports People with Disabilities

Although researchers are just beginning to learn about the medical benefits associated with cannabis, they already know that cannabis can help treat several debilitating diseases and improve daily life for millions of people around the world.

Some of the illnesses it can help treat include: glaucoma, post-traumatic stress disorder (PTSD), epilepsy, anxiety, multiple sclerosis, Alzheimer’s disease, inflammatory bowel diseases, lupus, arthritis, Crohn’s disease, Parkinson’s disease, chronic traumatic encephalopathy (CTE), nausea, and many more.

Veterans Rally for Cannabis

There is enough clinical data and mountains of anecdotal evidence to say that cannabis has medical benefits, but it remains a Schedule I substance. Hundreds of thousands of Veterans have rallied for legal medical cannabis.

If there is no one better than you for the veterans, then legalize cannabis!

Colorado Infrastructure Benefits from Cannabis

Since 2014, Colorado’s infrastructure has seen a significant improvement and much of this is due to the tax revenue from legal cannabis. In 2016, Colorado generated more than $1.3 billion in revenue from the sale of legal marijuana and this provided the state with almost $200 million in tax revenue.

If the government starts to go after states with legal recreational cannabis programs like Colorado, we expect to see the pace of infrastructure improvements slow down significantly.

Our infrastructure already needs a facelift. Why not let cannabis be the reason why America has even better schools, roads, public services, and hospitals.

Rollback of Legal Cannabis to Cause Debt to Spike

President Trump has said that nobody knows more than he does about trade and debt. During his presidential campaign, he frequently rallied up his crowds by putting the blame on past presidents (especially Obama) for the incredibly high debt level. On this front, President Trump is right. America is currently drowning in debt. He is also right that Obama is the cause of this debt.

His execution is off though and he is listening to some of the wrong people. The rollback of legal recreational marijuana will not help reduce our debt levels. Shutting off this revenue stream and destroying hundreds of thousands of jobs will only exacerbate the current situation.

Canada Capitalizes on Cannabis Trade Opportunities

28 states have legalized medical cannabis and eight states and the District of Columbia have legalized recreational cannabis. This revolution is not just taking place in the America. We are seeing cannabis reform taking place all around the world as countries like Australia, Brazil, Canada, Germany, Jamaica, Mexico, Netherlands, Paraguay, Portugal, Puerto Rico, and Uruguay have taken steps to legalize cannabis.

When it comes to trade, legal cannabis represents a huge opportunity and the we are behind the curve. We are already missing out on billion-dollar opportunities and letting other countries capitalize on America’s absence.

An example of this is Canada. They are selling cannabis to Germany since it only allows medical cannabis to be imported.

Important Investor Disclosures 

Disclosure.  Compensated Affiliate.  This report was authored by and is property of StoneBridge Partners LLC.  All information and data relied upon in drafting this report is publicly available. The author believes and considers its sources to be reliable, but does not guarantee the accuracy or completeness of any information contained in this report.  Any and all information, data, analyses and opinions are provided for informational purposes only and is not intended, in any manner, as investment advice.  Any projections or other information generated by StoneBridge Partners LLC regarding the likelihood of various investment outcomes are hypothetical in nature, do not reflect actual investment results, and are not guarantees of future results.  None of the material contained in this report is intended as a solution or offer to sell or purchase a specific stock or any other investment.  This report is not directed to, or intended for distribution or use by, any person or entity that is a citizen, resident or located in any municipality, state, country or other jurisdiction where the distribution, publication, availability, or use of this report is contrary to any governing law or regulation.  The securities discussed in this report may not be eligible for purchase and/or sale in certain jurisdictions or by particular individuals.  It is important that you check any and all governing laws and/or regulations that may be applicable in your jurisdiction.  Investing in securities of issuers organized outside of the United States, including ADRs, entail certain risks.  The securities of non-United States issuers may not be registered with, nor be subject to the reporting requirements of the United States Securities and Exchange Commission.  Please contact a Financial Advisor for professional adviceregarding any and all securities investments.  This report is intended for informational purposes only.  StoneBridge Partners LLC’s officers, directors, employees, affiliates, or subsidiaries may have positions in securities covered by StoneBridge Partners LLC.  StoneBridge Partners LLC receives compensation from the company and/or has a position in the securities mentioned inthis report

Share Share - Facebook Share - Twitter


Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Mushroomstocks.com. Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.


Top Stories

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.

Fatal error: Uncaught ErrorException: md5_file(/home/useaicwl/public_html/wp-content/litespeed/css/ba9ee749a33f09ea0ac518e73294751c.css.tmp): failed to open stream: No such file or directory in /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimizer.cls.php:126 Stack trace: #0 [internal function]: litespeed_exception_handler(2, 'md5_file(/home/...', '/home/useaicwl/...', 126, Array) #1 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimizer.cls.php(126): md5_file('/home/useaicwl/...') #2 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimize.cls.php(797): LiteSpeed\Optimizer->serve('https://mushroo...', 'css', true, Array) #3 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimize.cls.php(319): LiteSpeed\Optimize->_build_hash_url(Array) #4 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimize.cls.php(252): LiteSpeed\Optimize->_optimize() #5 /home/useaicwl/public_html/wp-includes/class-wp-hook.php(310): LiteSpeed\Optimize->f in /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimizer.cls.php on line 126